Key result
The force-generating capacity of the β/slow myosin isoform (type I) was weaker than the fast myosin isoform (type II) (P < 0.05), whereas different fast myosin isoforms were indistinguishable.
Why the study?
Does the force-generating capacity differ between fast and slow human myosin isoforms?
Does the force-generating capacity differ between fast and slow human myosin isoforms?
p-value: p=< 0.05
The study demonstrates a single fibre in vitro motility assay that reveals the β/slow myosin isoform has a weaker force-generating capacity than fast myosin isoforms.
In vitro assay distinguishes myosin isoform mechanics; leaves open translation to human cardiac or skeletal muscle function.
Muscle, motor unit and muscle fibre type-specific differences in force-generating capacity have been investigated for many years, but there is still no consensus regarding specific differences between slow- and fast-twitch muscles, motor units or muscle fibres. This is probably related to a number of different confounding factors disguising the function of the molecular motor protein myosin. We have therefore studied the force-generating capacity of specific myosin isoforms or combination of isoforms extracted from short single human muscle fibre segments in a modified single fibre myosin in vitro motility assay, in which an internal load (actin-binding protein) was added in different concentrations to evaluate the force-generating capacity. The force indices were the x-axis intercept and the slope of the relationship between the fraction of moving filaments and the α-actinin concentration. The force-generating capacity of the β/slow myosin isoform (type I) was weaker (P < 0.05) than the fast myosin isoform (type II), but the force-generating capacity of the different human fast myosin isoforms types IIa and IIx or a combination of both (IIax) were indistinguishable. A single fibre in vitro motility assay for both speed and force of specific myosin isoforms is described and used to measure the difference in force-generating capacity between fast and slow human myosin isoforms. The assay is proposed as a useful tool for clinical studies on the effects on muscle function of specific mutations or post-translational modifications of myosin.
No takes yet. Share an insight, caveat, or question.
Li et al. (2010) studied this question. β/slow myosin isoform (type I) vs. fast myosin isoform (type II) was evaluated on Force-generating capacity (x-axis intercept and slope of the relationship between the fraction of moving filaments and α-actinin concentration) (p=< 0.05). The force-generating capacity of the β/slow myosin isoform (type I) was weaker than the fast myosin isoform (type II) (P < 0.05), whereas different fast myosin isoforms were indistinguishable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: